Page 2 - Best Myeloma doctors: TOP 67 doctors

HU KAI

Member of the Professional Committee of Geriatric Oncology, Chinese Geriatric Society.

Member of the First Chinese T-cell Lymphoma Working Group of the Professional Committee of Oncohematology of the Chinese Anti-Cancer Association.

Member of the Professional Committee on Hematopoietic Stem Cell Transplantation and Cell Therapy, Chinese Association for Medical Education.

Chairman of the Expert Committee on Accurate Diagnosis and Treatment of Blood Tumors, Beijing Health Protection Association.

Member of the Professional Committee of Hematology of Beijing Research Association.

Member of the Professional Committee of Clinical Research of Beijing Cancer Association.

Conducts in-depth research in the field of immunotherapy, biomarkers, is well acquainted with the latest international standards of diagnostics and treatment of lymphoma. Participates in 20 international and national clinical studies on diagnostics and treatment of lymphomas and multiple myeloma.

Specialization:

multidisciplinary complex treatment of hematological malignancies

early diagnosis of lymphoma, multiple myeloma, leukemia

complex standardized treatment based on drug chemotherapy, molecular targeted therapy, autologous/allogeneic hematopoietic stem cell transplantation and biological therapy

Education and Specialization

• 2006: Kocaeli University Faculty of Medicine
• 2014: Akdeniz University Faculty of Medicine, Internal Medicine
• 2018: Akdeniz University Faculty of Medicine, Medical Oncology

Experience

• 2006 - 2008: Konya Derebucak District Hospital
• 2009 - 2015: Akdeniz University Hospital
• 2015: Antalya Kaş State Hospital
• 2015 - 2016: İnönü University Faculty of Medicine
• 2016 - 2021: Akdeniz University Hospital
• 2021 - 2023: Antalya Training and Research Hospital

Prof. Dr. Ceyhun Bozkurt is a respected Pediatric Hematologist-Oncologist. He is known for his work in childhood blood disorders and cancers. He graduated from Cerrahpaşa Faculty of Medicine. He holds specializations in both Pediatrics and Pediatric Oncology. Since 2019, he has been Professor and Clinical Director at Bahçelievler Medical Park Hospital. He also serves as Vice Director of the Stem Cell Transplant Unit.

Dr. Bozkurt has published over 40 peer-reviewed articles. He is recognized for his work in leukemia, bone marrow transplantation, and stem cell therapy. He is a member of organizations such as SIOP and EBMT. His memberships show his dedication to high standards in clinical care and research.

Kodchanut Litleaungdej, M.D.

• Dr. Jaume Mora Graupera specializes in Myeloma treatment.
• He employs chemotherapy, stem cell transplants, and targeted therapy.
• Trained in the USA at Weill Cornell Medicine and Memorial Sloan Kettering.
• Directs Hematology Oncology Department at Sant Joan De Déu in Barcelona.
• Member of the American Society of Clinical Oncology, representing high professionalism.
• Offers remote consultations for Myeloma patients, enhancing accessibility.
• Fluent in English and Spanish, facilitating communication with diverse patients.

• Specializes in Myeloma treatment, utilizing advanced methods.
• Myeloma therapies include stem cell transplant, chemotherapy, and targeted therapy.
• International practice in countries with leading cancer research.
• Certified Hematologist, expertise in bone marrow transplantation.
• Member of professional hematological societies, ensuring up-to-date practices.
• Offers online consultations for Myeloma patients worldwide.
• Speaks multiple languages, enhancing patient comfort and understanding.

• Dr. Eckhart Weidemann specializes in advanced Myeloma treatment.
• Utilizes chemotherapy, stem cell transplant, and targeted therapy for Myeloma.
• International practice in Germany and research collaborations worldwide.
• Holds vital hematology certifications, ensuring expert care.
• Member of esteemed hematology and oncology societies.
• Offers online consultations for Myeloma patients globally.
• Fluent in German and English, facilitating diverse patient communication.

Medical Experience:

- 2024 - Present: Memorial Şişli Hospital  

 Specialist in Internal Medicine and Hematology / Istanbul

- 2017 - 2024: Istanbul Florence Nightingale Hospital  

 Specialist in Internal Medicine and Hematology / Istanbul

- 2015 - 2017: Eskişehir Yunus Emre State Hospital  

 Hematology Specialist - Compulsory Service / Eskişehir

Medical Education:

- 2020 - 2024: Istanbul Florence Nightingale Hospital  

 Demiroğlu Bilim University, Faculty of Medicine / Istanbul, Turkey

- 2017 - 2020: Istanbul Florence Nightingale Hospital  

 Demiroğlu Bilim University, Faculty of Medicine / Istanbul, Turkey

- 2011 - 2015: Eskişehir Osmangazi University, Faculty of Medicine, Department of Hematology / Eskişehir, Turkey

- 2009 - 2011: Harvard University, Faculty of Medicine / Boston, USA

- 2000 - 2008: Ankara University, Faculty of Medicine / Ankara, Turkey

- 1994 - 2000: Ankara University, Faculty of Medicine / Ankara, Turkey

Attended Professional Trainings, Courses, and Conferences:

- European Society for Blood and Marrow Transplantation, 3rd EBMT International Transplant Course, Barcelona, Course, 07.09.2018-09.09.2018 (International)

- Turkish Academy of Blood Science, Lymphoma Masterclass, Istanbul, Course, 01.09.2016-01.03.2017 (National)

- Advanced Life Support Course, Istanbul

Membership in Professional Associations:

- European Society for Blood and Marrow Transplantation

- Turkish Academy of Blood Science

- Advanced Life Support Course

Dr. Francesc Cobo Valien graduated from the Faculty of Medicine of the University of Barcelona in 1990.

He received his specialization in oncohematology at the Hospital Clínic de Barcelona in 1995. He combined medical practice and research activities in the period 1996-2002.

He received his Doctor of Medicine degree from the University of Barcelona in 2002.

Dr. Kobo continues his research and has been awarded grants:

•Interdepartmental Commission for Innovation of the Generalitat de Catalunya

•Scholarship Fund Universitaria Agustí Pedro i Pons

•Farreras Valentí & Schering Plough School of Hematology Scholarship

•Award for the best report at the Council of the Spanish Hematology Association

•Grant from the Catalan Society of Hematology

Specialization:

•Lymphoma

•Acute leukemia

•Chronic leukemia

•Autoimmune pancytopenia

Dr. Michael Shapira is a specialist in Bone Marrow Transplantation with over 20 years of experience. He graduated from the Hebrew University Medical School in 1999. He completed his training in internal medicine at Hadassah Medical Center.

Dr. Shapira is a senior physician in the Bone Marrow Transplantation department at Hadassah. He has played a key role in many successful transplants and has helped maintain high patient survival rates. He is known for his clinical skills and commitment to improving transplantation medicine.

Dr. Dror Levin is a senior pediatrician and director of the blood disorder and bone cancer (sarcoma) treatment departments at Children's Hospital "Dana" and Medical Center "Sourasky" respectively. He is a specialist in pediatric medicine, hematology, and oncology, with additional experience studying abroad at the Rizzoli Orthopaedic Institute in Italy.

Dr. Leylagül Kaynar is a hematologist with broad experience in clinical hematology, bone marrow transplantation, and apheresis. She completed her medical degree and specialist training at Erciyes University in Turkey. There, she worked as Assistant Professor, Associate Professor, Director of the Apheresis Unit, and Head of the Hematology Department.

Dr. Kaynar gained international research experience as a Visiting Research Scholar at Duke University in the USA. She also led the Hematology and Bone Marrow Transplantation Department at the Bahrain Oncology Center, where she improved hematology care in the region. Dr. Kaynar is now Professor and Head of Hematology and Bone Marrow Transplantation at Medipol Mega University Hospital in Turkey. She is known for her leadership and contributions to hematology and transplantation services.

Univ.-Prof. Dr. Wolfgang Johannes Köstler is a board-certified specialist for Internal Medicine, Hematology/Oncology, and Intensive Care Medicine who specializes in hematology & internal oncology, intensive care medicine. He is one of the top-rated breast cancer and sarcoma oncologist specialists and has extensive experience in the field and has received degrees from the Medical University of Vienna and the Weizmann Institute of Science. He has also had special training at Memorial Sloan-Kettering Cancer Center and Royal Prince Alfred Hospital.

Dr. Ilia Kirshner is a hematologic oncologist with expertise in blood disorders, brain tumors, and prostate cancer. He is a Clinical Assistant Professor of Medicine at The Icahn School of Medicine at Mount Sinai.

Dr. Kirshner has led and contributed to important clinical trials. He was involved in a phase III study on enzalutamide for castrate-resistant prostate cancer. He completed fellowships in hematology (1995) and medical oncology (1994) at Montefiore Medical Center. He also finished his internal medicine residency at St. Luke’s-Roosevelt Hospital Center in 1990.

Dr. Herishanu Yair is a hematologist with 25 years of experience. He specializes in chronic lymphocytic leukemia (CLL). He is skilled in bone marrow transplantation, immunotherapy, CAR T-cell therapy, and leukemia chemotherapy.

Dr. Herishanu has received several awards, including the Young Investigator Research Prize, Clinical Excellence Prize, and Klitzberg Oncology Award. He has made important contributions to CLL research. His work includes many published studies and research grants from leading institutions.

He is a member of the Israeli and American Hematology Associations. This highlights his expertise and dedication to the field of hematology.

Hematology

Fields of Study and Interests

• Approach to Anemia

• lymphomas

• Multiple Myeloma

• Myeloproliferative Diseases

• thrombocytopenia

• Bleeding Diathesis

• Approach to lymphadenopathy/ splenomegaly

• Acute Leukemias

• Chronic Leukemias

• Approach to Anemia

• lymphomas

• Multiple Myeloma

• Myeloproliferative Diseases

• thrombocytopenia

• Bleeding Diathesis

• Approach to lymphadenopathy/ splenomegaly

• Acute/ Chronic Leukemias

Education

• Undergraduate Istanbul Faculty of Medicine Istanbul University 2007

• Master's Degree Internal Medicine USA Marmara University Faculty of Medicine 2012

PhD Hematology Clinic Istanbul Training and Research Hospital 2018

• Associate Professor Hematology Clinic Prof.Dr.Cemil Taşçıoğlu Training and Research Hospital

2019

Career

• Assistant Dr. Istanbul University Cerrahpaşa Faculty of Medicine General Surgery / USA 2007-

2008

• Assistant Dr. Marmara University Faculty of Medicine Internal Medicine USA 2008-2012

• Expert Dr. Mardin Derik State Hospital 2013-2015

• Minor Assistant Dr. Istanbul Training and Research Hospital Hematology Clinic 2015-2018

• Expert Dr. Prof. Dr. Cemil Taşçıoğlu Training and Research Hospital Hematology Clinic 2018-2019

• Associate Professor Prof. Dr. Cemil Taşçıoğlu Training and Research Hospital Hematology Clinic

2019-2020

• Associate Professor Istanbul Başakşehir Çam and Sakura City Hospital Hematology Clinic 2020

• Associate Professor Bozyaka Training and Research Hospital Hematology Clinic 2020-2021

• Associate Professor Istinye University Faculty of Medicine, Department of Internal Medicine, Liv

Vadistanbul Hospital 2021-2023

Publications: Eren R, Doğu MH, Emir S, Huq GE, Okçu O, Altındal Ş, Yokuş O, Suyanı E.

Rethinking the usefulness of bone marrow biopsy on treatment decision in CLL patients at